{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-014872","form_type":"8-K","ticker":"LUCD","cik":"0001799011","company_name":"Lucid Diagnostics Inc.","filed_at":"2025-09-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.026600+00:00","generated_at":"2026-05-17T05:41:23.544857+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Lucid Diagnostics appoints John R. Palumbo, healthcare veteran, to board effective Sept 22, 2025","bullets":["John R. Palumbo appointed as Class B director, effective September 22, 2025, designated by convertible note holders.","Palumbo brings 40 years of healthcare leadership, including roles at AmerisourceBergen, Allscripts, and ValueHealth.","He will receive cash fees and equity awards per non-employee director compensation policy.","He currently serves on boards of PM Pediatrics, ivWatch, Qless, and chairs Brado advisory board."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-014872","json":"https://secwatch.observer/filing/0001493152-25-014872.json","markdown":"https://secwatch.observer/filing/0001493152-25-014872.md","text":"https://secwatch.observer/filing/0001493152-25-014872.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799011/000149315225014872/0001493152-25-014872-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799011/000149315225014872/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T05:41:23.544857+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}